Real-World Outcomes of Enfortumab Vedotin and Pembrolizumab in Advanced Urothelial Carcinoma: A Multicenter Retrospective Analysis.

Saved in:
Bibliographic Details
Title: Real-World Outcomes of Enfortumab Vedotin and Pembrolizumab in Advanced Urothelial Carcinoma: A Multicenter Retrospective Analysis.
Authors: Jain, Prateek1,2, Naqvi, Syed Arsalan Ahmed1,3, Tripathi, Nikita1,4, Oberoi, Japneet K1, Humayun, Muhammad Abdullah1, Zakharia, Yousef1, Orme, Jacob J5, Kase, Adam6, Childs, Dan S5, Chen, Ruqin6, Riaz, Irbaz B1, Singh, Parminder1 Singh.Parminder@mayo.edu
Source: Clinical Genitourinary Cancer. Dec2025, Vol. 23 Issue 6, pN.PAG-N.PAG. 1p.
Database: Academic Search Ultimate
Description
ISSN:15587673
DOI:10.1016/j.clgc.2025.102453